Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1094.4000 -14.80 (-1.33%)
NSE Sep 12, 2025 15:31 PM
Volume: 794.2K
 

1094.40
-1.33%
Geojit BNP Paribas
with multiple regulatory milestones lined up in the coming quarters. Execution of the pipeline delivery and expansion initiatives is expected to support long-term value creation. Therefore, we maintain our rating on the stock at BUY, with rolledforward target price of Rs. 1,348, based on 17.5x FY27x Adj. EPS....
Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1132.4
More from Aurobindo Pharma Ltd.
Recommended